Whole Exome Analysis of NIAAA Clinical Center pATIENTS

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition to Life Technologies Corporation for whole exome analysis of NIAAA Clinical Center patients. The analysis has previously been performed on over 2000 patients using the AmpliSeq Exome enrichment system and sequenced on the ION sequencing platform. The use of a single enrichment and sequencing platform with consistent information content is essential for analysis of samples screened at different times. • The contract is for whole exome analysis of NIAAA Clinical Center patients. • The analysis has previously been performed on over 2000 patients. • The AmpliSeq Exome enrichment system and ION sequencing platform will be used. • The contract is a non-competitive sole source contract. • The contract will be awarded to Life Technologies Corporation.